Nasdaq · Pharmaceutical Preparations · EDGAR filings (CIK 1444192) · 5 signals · 0 setups · updated Aug 16, 2026
What the filings say Pressure ▼
The company can sell stock into the market any day at prevailing prices — steady supply.
Radar 58 (elevated attention) · dilution pressure high · listing risk elevated · governance risk low · runway 12.8 mo · strongest signal: ATM program (Aug 6, 2026)
Direction is stated for existing shareholders (▼ more shares / survival or listing risk; ▲ insiders or holders buying). It is a characterization of the filings, not a forecast or a recommendation.
16.3Mshares outstanding as of Jun 15, 2026 · was 15.5M Feb 12, 2026
Runway = liquidity ÷ monthly operating burn at the latest reported period · balance sheet 47 days old. A financing after the balance-sheet date is the main reason a figure can be stale — check the timeline below for offerings since then.
Signal timeline
Last 30 days of filing signals plus current balance-sheet flags, newest first. ▼ pressure · ▲ support · hover a score for its components; every row links to the filing.
Date
Signal
Evidence
Score
Aug 6, 2026
▼ATM program
“atm” language in 8-K (EX-99.1) filed 2026-08-06 filing